PT  - JOURNAL ARTICLE
ED  - Vidt, Donald G.
AU  - Lefkovits, Jeffrey
AU  - Topol, Eric J.
TI  - The clinical role of platelet glycoprotein Ilb/IIIa receptor inhibitors in ischemic heart disease
DP  - 1996 May 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 181--189
VI  - 63
IP  - 3
4099  - http://www.ccjm.org/content/63/3/181.short
4100  - http://www.ccjm.org/content/63/3/181.full
SO  - Cleve Clin J Med1996 May 01; 63
AB  - SUMMARY The platelet glycoprotein (GP) Ilb/IIIa receptor antagonists are powerful new antiplatelet drugs that show promise in reducing complications of coronary angioplasty and acute coronary syndromes.